MoneyWorks4Me

Alivus Life Sciences - Quaterly Results

31 Jul 2026 Evaluate
The Revenue for the quarter ended  June 2026 of Rs. 6404.14 millions grew by 6.41 % from Rs. 6018.46 millions.A good growth in profit of 31.71% reported to Rs. 1600.76  millions over Rs. 1215.35 millions of corresponding previous quarter.Operating Profit saw a handsome growth to 2341.15 millions from 1812.96 millions in the quarter ended June 2026.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 6404.14 6018.46 6.41 6404.14 6018.46 6.41 25518.32 23868.84 6.91
Other Income 224.01 89.85 149.32 224.01 89.85 149.32 604.11 345.70 74.75
PBIDT 2341.15 1812.96 29.13 2341.15 1812.96 29.13 8576.95 7171.54 19.60
Interest 13.07 12.51 4.48 13.07 12.51 4.48 53.72 24.14 122.54
PBDT 2328.08 1800.45 29.31 2328.08 1800.45 29.31 8266.66 7147.40 15.66
Depreciation 205.85 170.64 20.63 205.85 170.64 20.63 753.57 606.09 24.33
PBT 2122.23 1629.81 30.21 2122.23 1629.81 30.21 7513.09 6541.31 14.86
TAX 521.47 414.46 25.82 521.47 414.46 25.82 1868.26 1685.04 10.87
Deferred Tax 18.73 25.10 -25.38 18.73 25.10 -25.38 29.34 60.64 -51.62
PAT 1600.76 1215.35 31.71 1600.76 1215.35 31.71 5644.83 4856.27 16.24
Equity 245.48 245.26 0.09 245.48 245.26 0.09 245.47 245.07 0.16
PBIDTM(%) 36.56 30.12 21.36 36.56 30.12 21.36 33.61 30.05 11.87
Peers
Company Name CMP
Sun Pharma. Inds. 1848.20
Dr. Reddys Labs. 1216.15
Cipla 1396.75
Lupin 2088.80
Zydus Lifesciences 1206.20
View more..